Multiple sclerosis laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
==== CSF analysis: ==== | ==== CSF analysis: ==== | ||
[[CSF]] analysis mostly used to rule out other [[differential diagnosis]] of [[MS]] since it’s not needed in [[MS]] patients who have typical clinical presentation and [[MRI]] findings | [[CSF]] analysis mostly used to rule out other [[differential diagnosis]] of [[MS]] since it’s not needed in [[MS]] patients who have typical clinical presentation and [[MRI]] findings. One of the most important findings in [[CSF]] analysis of [[MS]] patients is the presence of [[Oligoclonal bands|oligoclonal IgG bands]] and can be seen in more than 95% of these patients. [[Oligoclonal bands]] are an indicator of disease progression.<ref name="pmid11456302">{{cite journal |vauthors=McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS |title=Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis |journal=Ann. Neurol. |volume=50 |issue=1 |pages=121–7 |date=July 2001 |pmid=11456302 |doi= |url=}}</ref><ref name="pmid2245296">{{cite journal |vauthors=McLean BN, Luxton RW, Thompson EJ |title=A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications |journal=Brain |volume=113 ( Pt 5) |issue= |pages=1269–89 |date=October 1990 |pmid=2245296 |doi= |url=}}</ref><ref name="pmid23431079">{{cite journal |vauthors=Dobson R, Ramagopalan S, Davis A, Giovannoni G |title=Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude |journal=J. Neurol. Neurosurg. Psychiatry |volume=84 |issue=8 |pages=909–14 |date=August 2013 |pmid=23431079 |doi=10.1136/jnnp-2012-304695 |url=}}</ref> | ||
==References== | ==References== | ||
Revision as of 07:26, 1 March 2018
|
Multiple sclerosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Multiple sclerosis laboratory findings On the Web |
|
American Roentgen Ray Society Images of Multiple sclerosis laboratory findings |
|
Risk calculators and risk factors for Multiple sclerosis laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Laboratory Findings
CSF analysis:
CSF analysis mostly used to rule out other differential diagnosis of MS since it’s not needed in MS patients who have typical clinical presentation and MRI findings. One of the most important findings in CSF analysis of MS patients is the presence of oligoclonal IgG bands and can be seen in more than 95% of these patients. Oligoclonal bands are an indicator of disease progression.[1][2][3]
References
- ↑ McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (July 2001). "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis". Ann. Neurol. 50 (1): 121–7. PMID 11456302.
- ↑ McLean BN, Luxton RW, Thompson EJ (October 1990). "A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications". Brain. 113 ( Pt 5): 1269–89. PMID 2245296.
- ↑ Dobson R, Ramagopalan S, Davis A, Giovannoni G (August 2013). "Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude". J. Neurol. Neurosurg. Psychiatry. 84 (8): 909–14. doi:10.1136/jnnp-2012-304695. PMID 23431079.